Total Payments
$676.20
2024 Payments
$190.63
Companies
7
Transactions
23
Medicare Patients
3,938
Medicare Billing
$626,206
Payment Breakdown by Category
Food & Beverage$676.20 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $676.20 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $159.56 | 6 | $0 (2020) |
| ABIOMED | $155.96 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $126.55 | 2 | $0 (2019) |
| Daiichi Sankyo Inc. | $108.56 | 6 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $48.23 | 3 | $0 (2020) |
| Amgen Inc. | $42.67 | 3 | $0 (2020) |
| Ardelyx, Inc. | $34.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $190.63 | 3 | ABIOMED ($155.96) |
| 2020 | $199.51 | 12 | Daiichi Sankyo Inc. ($108.56) |
| 2019 | $174.66 | 7 | Fresenius USA Marketing, Inc. ($132.09) |
| 2017 | $111.40 | 1 | AstraZeneca Pharmaceuticals LP ($111.40) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/26/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $29.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $126.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/16/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Anemia | ||||||
| 11/10/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEPHROLOGY | ||||||
| 10/26/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: NEPHROLOGY | ||||||
| 10/20/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Anemia | ||||||
| 08/11/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Anemia | ||||||
| 07/21/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Nephrology | ||||||
| 07/13/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Anemia | ||||||
| 06/08/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Anemia | ||||||
| 05/18/2020 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Phosphate binder for ESRD | ||||||
| 03/19/2020 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Phosphate binder for ESRD | ||||||
| 01/14/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Nephrology | ||||||
| 01/07/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: Anemia | ||||||
| 12/19/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $98.80 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/17/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEPHROLOGY | ||||||
| 12/10/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/20/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/24/2019 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Phosphate binder for ESRD | ||||||
| 10/08/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Nephrology | ||||||
| 05/04/2017 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $111.40 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 239 | 472 | $564,420 | $78,181 |
| 2022 | 7 | 278 | 570 | $649,838 | $90,033 |
| 2021 | 28 | 1,212 | 1,739 | $670,277 | $137,633 |
| 2020 | 36 | 2,209 | 4,985 | $741,443 | $320,358 |
Total Patients
3,938
Total Services
7,766
Medicare Billing
$626,206
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 127 | $264,160 | $33,773 | 12.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 109 | 165 | $113,850 | $20,869 | 18.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 80 | $40,000 | $7,158 | 17.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 13 | 20 | $33,400 | $4,506 | 13.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 26 | $65,260 | $4,130 | 6.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 25 | 25 | $22,375 | $4,028 | 18.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 29 | $25,375 | $3,718 | 14.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 24 | 141 | $280,590 | $38,213 | 13.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 121 | 170 | $111,860 | $20,181 | 18.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 124 | $59,520 | $8,837 | 14.8% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 18 | 39 | $62,400 | $8,746 | 14.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 41 | 41 | $34,973 | $5,985 | 17.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 34 | $82,960 | $5,195 | 6.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 21 | $17,535 | $2,877 | 16.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 94 | 192 | $295,060 | $54,091 | 18.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 103 | 402 | $145,292 | $32,411 | 22.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 75 | 96 | $59,213 | $12,893 | 21.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 38 | 51 | $54,434 | $12,166 | 22.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 31 | 31 | $24,800 | $5,226 | 21.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 34 | 34 | $24,421 | $5,051 | 20.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 30 | $12,300 | $2,516 | 20.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2021 | 48 | 54 | $6,687 | $2,229 | 33.3% |
| 82306 | Vitamin d-3 level | Office | 2021 | 46 | 52 | $4,618 | $1,539 | 33.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 11 | 11 | $6,963 | $1,281 | 18.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 32 | 34 | $11,659 | $1,258 | 10.8% |
About Dr. Alan Moreno, MD
Dr. Alan Moreno, MD is a Nephrology healthcare provider based in Oshkosh, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1427468651.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alan Moreno, MD has received a total of $676.20 in payments from pharmaceutical and medical device companies, with $190.63 received in 2024. These payments were reported across 23 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($676.20).
As a Medicare-enrolled provider, Moreno has provided services to 3,938 Medicare beneficiaries, totaling 7,766 services with total Medicare billing of $626,206. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Oshkosh, WI
- Active Since 04/28/2014
- Last Updated 04/15/2024
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1427468651
Products in Payments
- Velphoro (Drug) $159.56
- Impella (Device) $155.96
- INJECTAFER (Drug) $108.56
- JYNARQUE (Drug) $48.23
- IBSRELA (Drug) $34.67
- Parsabiv (Drug) $29.24
- LOKELMA (Drug) $15.15
- Parsabiv (Biological) $13.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.